Key result
Stereotactic arrhythmia radioablation is a promising noninvasive therapy that has demonstrated early safety and efficacy in treating drug-refractory ventricular tachycardia and atrial fibrillation.
Why the study?
Does stereotactic arrhythmia radioablation reduce arrhythmias in patients with drug-refractory ventricular tachycardia or atrial fibrillation?
Does stereotactic arrhythmia radioablation reduce arrhythmias in patients with drug-refractory ventricular tachycardia or atrial fibrillation?
Stereotactic arrhythmia radioablation is a promising, noninvasive alternative for patients with refractory ventricular tachycardia or atrial fibrillation who have failed conventional catheter ablation.
Answers are grounded in this paper and cite their sources.
Supports expanded research into noninvasive ablation; leaves open routine adoption pending randomized trials.
PURPOSE OF REVIEW: Stereotactic radioablation is a commonly utilized technology to noninvasively treat solid tumors with precision and efficacy. Using a robotic arm mounted delivery system, multiple low-dose ionizing radiation beams are delivered from multiple angles, concentrating ablative energy at the target tissue. Recently, this technology has been evaluated for treatment of cardiac arrhythmias. This review will present the basic underlying principles, proof-of-principle studies, and clinical experience with stereotactic arrhythmia radioablation. RECENT FINDINGS: Most recently, stereotactic radioablation has been used to safely and effectively treat a limited number of patients with malignant arrhythmias, including ventricular tachycardia (VT) and atrial fibrillation (AF). Treatment protocols, outcomes, ongoing studies, and future directions will be discussed. Stereotactic radioablation is a well-established technology that has been shown to be a safe and effective therapy for patients with drug-refractory cardiac arrhythmias, including VT and AF. Further clinical evaluation to define safety and efficacy in larger populations of patients is needed.
No takes yet. Share an insight, caveat, or question.
Zei et al. (2017) conducted a review in Cardiac arrhythmias (Ventricular tachycardia and Atrial fibrillation). Stereotactic arrhythmia radioablation (STAR) was evaluated. Stereotactic arrhythmia radioablation is a promising noninvasive therapy that has demonstrated early safety and efficacy in treating drug-refractory ventricular tachycardia and atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: